The Community Catalyst created the Prescription Access Litigation Project (“PAL”) in 2001 to use class action litigation and public education to end pharmaceutical price inflation. The Community Catalyst is a national advocacy organization that encourages consumer and community participation in the molding of our health system to ensure quality, affordable health care for everyone. Visit the Web site at www.communitycatalyst.org.
According to PAL, prescription drug prices in the United States are the highest in the world and have become a significant barrier to increasing access to health care in the United States. Because of the drug industry’s powerful legislative lobby, PAL chose the courts as a value-added, relatively level playing field through which the industry’s alleged inflationary practices can be stopped.
